These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27314423)

  • 1. Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.
    Wang Y; Sun Y; Wang J; Yang Y; Li Y; Yuan Y; Liu C
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17166-75. PubMed ID: 27314423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer.
    Zhang P; Wu T; Kong JL
    ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells.
    Ghobadi M; Salehi S; Ardestani MTS; Mousavi-Khattat M; Shakeran Z; Khosravi A; Cordani M; Zarrabi A
    Eur J Pharm Biopharm; 2024 Aug; 201():114349. PubMed ID: 38848782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of MSNs@Keratin as pH/GSH dual responsive drug delivery system.
    Shang Y; Du J; Wang B; Lu P; Zhao Y; Yuan J
    J Biomater Sci Polym Ed; 2022 Aug; 33(11):1369-1382. PubMed ID: 35319342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
    Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.